IL92898A - Carboxylic acid quinoline acids are converted - Google Patents

Carboxylic acid quinoline acids are converted

Info

Publication number
IL92898A
IL92898A IL9289889A IL9289889A IL92898A IL 92898 A IL92898 A IL 92898A IL 9289889 A IL9289889 A IL 9289889A IL 9289889 A IL9289889 A IL 9289889A IL 92898 A IL92898 A IL 92898A
Authority
IL
Israel
Prior art keywords
amino
acid
fluoro
biphenyl
water
Prior art date
Application number
IL9289889A
Other languages
English (en)
Hebrew (he)
Other versions
IL92898A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL92898A0 publication Critical patent/IL92898A0/xx
Publication of IL92898A publication Critical patent/IL92898A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
IL9289889A 1989-01-17 1989-12-27 Carboxylic acid quinoline acids are converted IL92898A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/298,585 US4968702A (en) 1989-01-17 1989-01-17 Substituted quinolinecarboxylic acids

Publications (2)

Publication Number Publication Date
IL92898A0 IL92898A0 (en) 1990-09-17
IL92898A true IL92898A (en) 1994-11-28

Family

ID=23151154

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9289889A IL92898A (en) 1989-01-17 1989-12-27 Carboxylic acid quinoline acids are converted

Country Status (17)

Country Link
US (1) US4968702A (fr)
EP (1) EP0379145B1 (fr)
JP (1) JP3004025B2 (fr)
KR (1) KR0140076B1 (fr)
AT (1) ATE152711T1 (fr)
AU (1) AU624471B2 (fr)
CA (1) CA2007740C (fr)
DE (1) DE69030632T2 (fr)
DK (1) DK0379145T3 (fr)
ES (1) ES2100851T3 (fr)
GR (1) GR3023585T3 (fr)
HK (1) HK1008019A1 (fr)
IE (1) IE900169L (fr)
IL (1) IL92898A (fr)
NZ (1) NZ232111A (fr)
PH (1) PH26961A (fr)
ZA (1) ZA90299B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310732A (en) * 1986-02-03 1994-05-10 The Scripps Research Institute 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5393891A (en) * 1993-06-08 1995-02-28 The Du Pont Merck Pharmaceutical Company Immunoassay reagents and methods for detecting brequinar and analogs
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
WO1999038846A1 (fr) * 1998-01-30 1999-08-05 Procept, Inc. Agents immunosuppresseurs
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
AR037233A1 (es) 2001-09-07 2004-11-03 Euro Celtique Sa Piridinas aril sustituidas, composiciones farmaceuticas y el uso de dichos compuestos para la elaboracion de un medicamento
AR036873A1 (es) * 2001-09-07 2004-10-13 Euro Celtique Sa Piridinas aril sustituidas a, composiciones farmaceuticas y el uso de las mismas para la preparacion de un medicamento
MXPA05001642A (es) * 2002-08-13 2005-04-25 Warner Lambert Co Derivados de naftaleno como inhibidores de metaloproteinasas de matriz.
US7138412B2 (en) * 2003-03-11 2006-11-21 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives useful as serine protease inhibitors
WO2006115509A2 (fr) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
CA2898615A1 (fr) * 2013-01-28 2014-07-31 Viamet Pharmaceuticals, Inc. Composes inhibiteurs de metalloenzyme
KR20160079123A (ko) 2013-11-22 2016-07-05 젠자임 코포레이션 신경변성 질병을 치료하기 위한 신규한 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE287804C (fr) *
US2888346A (en) * 1955-08-22 1959-05-26 Gen Aniline & Film Corp Ultra-violet absorbing compounds
FR2166297A1 (en) * 1972-01-07 1973-08-17 Rosenberg Eli 2-(4-isopropylphenyl)quinoline-4-carboxylic acid - as a non-toxic, analgesic agent
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
EP0133244B1 (fr) * 1983-07-22 1990-12-05 E.I. Du Pont De Nemours And Company Acides phénylquinolinecarboxyliques et dérivés comme agents antitumoraux
EP0318093A3 (fr) * 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Acides dicarboxyliques des diaryl quinoléines et leur utilisation comme médicaments

Also Published As

Publication number Publication date
IL92898A0 (en) 1990-09-17
PH26961A (en) 1992-12-28
CA2007740A1 (fr) 1990-07-17
KR900011733A (ko) 1990-08-02
JP3004025B2 (ja) 2000-01-31
DE69030632D1 (de) 1997-06-12
GR3023585T3 (en) 1997-08-29
HK1008019A1 (en) 1999-04-30
DE69030632T2 (de) 1997-10-02
AU4850290A (en) 1990-07-26
US4968702A (en) 1990-11-06
DK0379145T3 (da) 1997-05-26
KR0140076B1 (ko) 1998-06-01
AU624471B2 (en) 1992-06-11
ATE152711T1 (de) 1997-05-15
EP0379145A3 (fr) 1991-07-17
EP0379145B1 (fr) 1997-05-07
CA2007740C (fr) 1999-12-07
JPH02229166A (ja) 1990-09-11
ES2100851T3 (es) 1997-07-01
IE900169L (en) 1990-07-17
NZ232111A (en) 1992-07-28
ZA90299B (en) 1990-10-31
EP0379145A2 (fr) 1990-07-25

Similar Documents

Publication Publication Date Title
IL92898A (en) Carboxylic acid quinoline acids are converted
US4812459A (en) Anti-hypertensive pyranopyridine compounds
US4668686A (en) Imidazoquinoline antithrombrogenic cardiotonic agents
US20050261281A1 (en) Pharmaceutical compounds
AU2681392A (en) Acyclic ethylenediamine derivatives as substance p receptor antagonists
EP1377555B1 (fr) Un derive de dioxino[2,3-g]quinoline-9-acide carboxylique en tant qu'antagoniste du recepteur nk3
IL92466A (en) History of arylpifridine and pharmaceutical preparations containing them
JP2008501762A (ja) バニロイドアンタゴニストとして有用なクロモン誘導体
CA1333606C (fr) Acides substitues de type 2-phenyl-4-quinonecarboxyliques
EP1659120A1 (fr) Derives de 3-substitue quinoline-4-carboxamide utilises comme antagonistes du recepteur NK3 et du recepteur NK2
NO139685B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
NO171847B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater
NZ209193A (en) Substituted tetrazolyl quinolone derivatives and pharmaceutical compositions
US4248879A (en) Benzopyranotriazoles
NO144110B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
US5110815A (en) 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and pharmaceutical use
NO163896B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive spiro-(1,8)-nafthyridin-dioner.
EP0638570A1 (fr) Compose tricyclique dote d'un effet antiallergique
EP0002562B1 (fr) Dérivés de la triazolo-quinoléine, procédés pour leur préparation et leur utilisation pharmaceutique
US5294611A (en) Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
US5216164A (en) 5-amino-5,6,7,8-tetrahydroquinolines and related compounds
WO1994020498A1 (fr) Derive de la benzylimidazopyridine utilise comme antagoniste du recepteur de l'angiotensine ii
JPS63313786A (ja) デカヒドロ−１Ｈ−ピリド〔１，２−ｆ〕フェナントリジン類およびデカヒドロピロロ〔１，２−ｆ〕フェナントリジン類
TW412535B (en) Anellated <beta>-carboline
JPS5818363A (ja) 複素環式置換アミノピラゾリン類およびその薬としての用途

Legal Events

Date Code Title Description
KB Patent renewed